↓ Skip to main content

A phase II randomized trial of sodium oligomannate in Alzheimer’s dementia

Overview of attention for article published in Alzheimer's Research & Therapy, September 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
twitter
5 X users

Citations

dimensions_citation
60 Dimensions

Readers on

mendeley
97 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A phase II randomized trial of sodium oligomannate in Alzheimer’s dementia
Published in
Alzheimer's Research & Therapy, September 2020
DOI 10.1186/s13195-020-00678-3
Pubmed ID
Authors

Tao Wang, Weihong Kuang, Wei Chen, Wenwei Xu, Liming Zhang, Yingjie Li, Hailin Li, Ying Peng, Yangmei Chen, Baojun Wang, Jinsong Xiao, Honghua Li, Chuanzhu Yan, Yifeng Du, Mouni Tang, Zhiyi He, Haibo Chen, Wei Li, Hong Lin, Shugui Shi, Jianzhong Bi, Huadong Zhou, Yan Cheng, Xiaoping Gao, Yihui Guan, Qiu Huang, Kewei Chen, Xianliang Xin, Jian Ding, Meiyu Geng, Shifu Xiao

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 97 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 97 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 12 12%
Researcher 10 10%
Student > Bachelor 8 8%
Student > Ph. D. Student 8 8%
Other 3 3%
Other 8 8%
Unknown 48 49%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 10 10%
Neuroscience 8 8%
Medicine and Dentistry 7 7%
Biochemistry, Genetics and Molecular Biology 6 6%
Agricultural and Biological Sciences 4 4%
Other 9 9%
Unknown 53 55%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 August 2021.
All research outputs
#1,950,216
of 24,226,848 outputs
Outputs from Alzheimer's Research & Therapy
#376
of 1,340 outputs
Outputs of similar age
#52,061
of 406,849 outputs
Outputs of similar age from Alzheimer's Research & Therapy
#22
of 46 outputs
Altmetric has tracked 24,226,848 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,340 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.3. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 406,849 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.